Zoono Group Limited (AU:ZNO) has released an update.
Zoono Group Limited successfully closed its rights issue, achieving full subscription and raising $2,884,656.89, with strong participation from major shareholders, including management and the Managing Director, Paul Hyslop. The funds are earmarked for technology development, expansions in China, India, and the USA, debt repayment, and working capital. Zoono specializes in long-lasting, environmentally-friendly antimicrobial products and has a global presence.
For further insights into AU:ZNO stock, check out TipRanks’ Stock Analysis page.